News

UPC Court of Appeal lowers threshold in establishing imminent patent infringement for generic launch

The UPC Court of Appeal has overturned a decision of the Lisbon Local Division and granted Boehringer Ingelheim (“Boehringer”) a provisional injunction for imminent patent infringement. In doing so, it has confirmed that completion of national pricing and reimbursement procedures for generic drugs may be sufficient to trigger injunctive relief.

Chambers and Partners 2026

We’re proud to announce that Potter Clarkson has once again been recognised in the Chambers UK Guide 2026.‍‍

Orange juice appeal pulped and FIFA broadcast rights affirmed

Two recent English Court of Appeal decisions show how legally binding agreements may arise in commercial situations despite the apparent absence of the usual contractual requirements.

A new lead candidate brings vaccine for Chagas disease closer to reality

When you hear “kissing bug,” you might picture something harmless or even endearing. But this insect delivers anything but affection; it transmits Trypanosoma cruzi, the parasite responsible for Chagas disease, a potentially deadly illness affecting millions worldwide.

Potter Clarkson ranked in Managing IP's IP STARS 2025

Potter Clarkson has been proudly recognised in Managing IP’s IP STARS 2025 rankings.

UK comparable trade marks: grace period ends soon

As 2025 draws to a close, brand owners face an important deadline that could affect their UK trade mark rights. From 1 January 2026, it is no longer possible to rely on evidence of use in the EU to maintain the validity of UK comparable trade marks (often called “Brexit clones”). This marks the end of the grace period for use, originally set out in the UK/EU Withdrawal Agreement.

The Legal 500 2026

Potter Clarkson has once again been highly recognised in the 2026 Legal 500 rankings, a leading guide for clients seeking top law firms, attorneys, and solicitors.

UPC grants first UK injunction

Following its previous widely-reported ruling earlier this year, the Mannheim Local Division has now issued its decision in respect of the UK aspect of the infringement proceedings brought by FujiFilm, marking the first time that the UPC has granted an injunction which applies to the UK.

What should I be asking IP firms to present in a tender?

Intellectual property (IP) is one of the most valuable assets a business can hold. Patents, trade marks, copyrights, and trade secrets are not just legal formalities, they are hugely valuable strategic tools that protect innovation and create competitive advantage.

Can space agriculture tackle the food crisis and how is IP enforced in space?

Space agriculture (or as you may know it, space-based AgTech, astroagriculture, exo-agriculture, off-earth farming or extraterrestrial food systems) refers to agricultural technologies and systems developed or tested in space.

Potter Clarkson launches landmark patent landscape analysis of the SynBio revolution

From engineered microbes cleaning up environmental waste to CRISPR-edited cells powering next-generation therapies, synthetic biology is shaping industries, economies, and everyday life.

The SPC manufacturing waiver in practice: legal framework and emerging jurisprudence

The SPC manufacturing waiver, introduced in 2019 under Regulation (EU) No 2019/933, marked a pivotal development in EU pharmaceutical law.

Can CRISPR and RNAi help us develop new and more sustainable fruits and vegetables?

Gene editing technologies like CRISPR and RNA interference (RNAi) are revolutionising agriculture.

What are the critical success factors procurement managers should prioritise when selecting an IP firm from tender responses?

When evaluating tender responses from IP law firms, procurement managers should prioritise the direct responses to their critical success factors (CSFs). This will ensure the selected firm is capable of delivering value and minimising risk.

Referral on EPO description amendments confirmed (G1/25 - “Hydroponics")

A Board of Appeal at the EPO has referred questions to the Enlarged Board of Appeal (EBA) in connection with inconsistencies between the claims and description of a European patent vs. those of a European patent application (pre-grant vs. post-grant).

Helping a green hydrogen technology company scale through strategic IP

GeoPura is a trailblazer within sustainable innovation. They provide a zero-emission solution for generating, storing, and distributing the energy needed to drive the global transition to clean power by giving customers the power to decarbonize their consumption of temporary, backup, off-grid, and grid augmentation energy.

We worked with this pioneering clean energy business to put in place the patent and trade mark protection needed to support the development and commercialisation of its hydrogen power technology and HPU™ brand. This strategy helped secure investment and accelerate growth.